YAMADA Consulting Group  CO.,LTD. Logo

YAMADA Consulting Group CO.,LTD.

Japanese consulting firm offering global M&A, strategy, and financial advisory services.

4792 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
千代田区丸の内1−8−1丸の内トラストタワーN館
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

YAMADA Consulting Group is one of Japan's largest independent consulting firms, providing a comprehensive range of management and financial advisory services. The company specializes in business consulting for small and medium-sized enterprises but also serves multinational corporations and government agencies. Core services include strategy development based on primary information, investment research, and M&A transaction support. With a direct presence in Asia, the Middle East, and the USA, and through strategic partnerships such as Clairfield International, YAMADA offers seamless cross-border M&A advisory and global consulting solutions. The firm's subsidiary, Yamada Consulting & Spire, acts as a regional headquarters to capitalize on opportunities in the Asian market.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for YAMADA Consulting Group CO.,LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-24 10:02
Post-Annual General Meeting Information
臨時報告書
Japanese 27.5 KB
2025-06-20 09:53
Governance Information
内部統制報告書-第36期(2024/04/01-2025/03/31)
Japanese 23.2 KB
2025-06-20 09:53
Registration Form
確認書
Japanese 8.6 KB
2025-06-20 09:52
Annual Report
有価証券報告書-第36期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2025-05-27 09:24
Regulatory News Service
臨時報告書
Japanese 19.6 KB
2025-01-10 03:36
Regulatory News Service
臨時報告書
Japanese 20.0 KB
2024-11-13 08:26
Interim Report
半期報告書-第36期(2024/04/01-2025/03/31)
Japanese 214.7 KB
2024-11-13 08:26
Regulatory News Service
確認書
Japanese 8.5 KB
2024-06-28 07:21
Regulatory News Service
臨時報告書
Japanese 23.7 KB
2024-06-28 06:18
Regulatory News Service
内部統制報告書-第35期(2023/04/01-2024/03/31)
Japanese 22.8 KB
2024-06-28 06:17
Regulatory News Service
確認書
Japanese 8.6 KB
2024-06-28 06:15
Annual Report
有価証券報告書-第35期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-13 06:38
Regulatory News Service
確認書
Japanese 8.5 KB
2024-02-13 06:37
Quarterly Report
四半期報告書-第35期第3四半期(2023/10/01-2023/12/31)
Japanese 197.9 KB
2023-11-13 08:23
Regulatory News Service
確認書
Japanese 8.5 KB

Automate Your Workflow. Get a real-time feed of all YAMADA Consulting Group CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for YAMADA Consulting Group CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SyntekaBio,Inc. Logo
AI drug discovery platform accelerating R&D with supercomputing, SaaS, and pre-made candidates.
South Korea 226330
Targetspot S.A. Logo
AdTech firm for digital audio monetization, connecting brands to publishers' audiences.
Belgium ALTGS
TechnoPro Holdings, Inc. Logo
Technology staffing and services group providing engineers and solutions for R&D and development.
Japan 6028
A holding company active in property rentals and marine seismic & defense R&D.
Virgin Islands (British) N/A
Holding company for real estate development, building management, and community-integrated hotels.
Japan 3271
The Lifestyle Group Logo
Developed luxury/well-being ventures & provided multimedia systems for franchise network growth.
Italy TLSG
Theranexus Logo
A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.
France ALTHX
THE WHY HOW DO COMPANY, Inc. Logo
A corporate regeneration platform for business turnarounds, M&A, and succession solutions.
Japan 3823
TME Pharma N.V. Logo
Developing therapies for aggressive cancers by neutralizing the tumor microenvironment.
Germany ALTME
TOKAI LEASE CO.,LTD. Logo
Manufactures and leases temporary buildings and fixtures for the construction sector.
Japan 9761

Talk to a Data Expert

Have a question? We'll get back to you promptly.